| Ron Linehan, MD | |
|
1533 Election House Rd Nw, Lancaster, OH 43130-9059 | |
| (740) 689-9500 | |
| (740) 689-9555 |
| Full Name | Ron Linehan |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 1533 Election House Rd Nw, Lancaster, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013917426 | NPI | - | NPPES |
| 2058973 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairfield Medical Center | Lancaster, OH | Hospital |
| Genesis Hospital | Zanesville, OH | Hospital |
| Hocking Valley Community Hospital | Logan, OH | Hospital |
| Entity Name | Fairfield Anesthesia Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205836871 PECOS PAC ID: 3173511342 Enrollment ID: O20040505000866 |
News Archive
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology, today announced that Roche has announced positive topline results from its trastuzumab emtansine (T-DM1) EMILIA Phase III trial.
One of the lines of research of OILTEBIA, a European science project coordinated by Universidad Carlos III de Madrid, is a method to detect breast cancer based on photoacoustics and which could become an alternative to mammography or sonogram.
Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on bmj.com today.
› Verified 6 days ago
| Entity Name | Precision Pain Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508035957 PECOS PAC ID: 0345326732 Enrollment ID: O20080326000197 |
News Archive
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology, today announced that Roche has announced positive topline results from its trastuzumab emtansine (T-DM1) EMILIA Phase III trial.
One of the lines of research of OILTEBIA, a European science project coordinated by Universidad Carlos III de Madrid, is a method to detect breast cancer based on photoacoustics and which could become an alternative to mammography or sonogram.
Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on bmj.com today.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ron Linehan, MD 200 Northland Blvd Fl 1, Cincinnati, OH 45246-3604 Ph: (513) 672-4128 | Ron Linehan, MD 1533 Election House Rd Nw, Lancaster, OH 43130-9059 Ph: (740) 689-9500 |
News Archive
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology, today announced that Roche has announced positive topline results from its trastuzumab emtansine (T-DM1) EMILIA Phase III trial.
One of the lines of research of OILTEBIA, a European science project coordinated by Universidad Carlos III de Madrid, is a method to detect breast cancer based on photoacoustics and which could become an alternative to mammography or sonogram.
Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on bmj.com today.
› Verified 6 days ago